Asia Leads the Charge as Tech ETFs Bleed
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
The week's most striking signal is a rush into Asian markets. Over $10.5B flowed into China ETFs in the past seven days. Japan added $4.4B and Taiwan pulled in $3.7B. That is a sharp break from the three-month trend, where Japan has been a net loser of nearly $16B as domestic investors rotated out.
Geography: Asia Wins, Brazil Bleeds
China's one-week flow imbalance hit 72, pointing to firm buying pressure. Taiwan is even tighter at 95.1, with almost no offsetting outflow. Both readings are well above the 65 threshold for strong demand. Emerging Markets as a whole added $3.1B for the week, on top of $13.4B over the past three months. The picture across Asia is broadly constructive. Japan machine tool orders in September rose 59% year-on-year to JPY 218,864M, according to ORTEX Alt Data. The order backlog climbed 50% over the same period. That industrial momentum feeds the case for continued allocation to Japan despite its bumpy three-month record.
Brazil is the week's main outflow story. It shed $1.2B in seven days, reversing a positive three-month trend where it had collected $4.8B. Israel also lost $325M for the week and sits on a three-month net outflow of $550M. India is leaking money on both timeframes: down $24M this week and $797M over three months.
Sector Rotation: Tech Falls, Financials Rise
Technology ETFs suffered a $4.2B outflow this week. That is the biggest sectoral drain by far, with a flow imbalance of just 35.6. Over three months, Tech had been a mild net inflow story at $2.7B, so this week marks a real reversal.
Financials took in $1.7B this week on a flow imbalance of 70.5. Over three months, Financials had been the worst-performing sector, losing $9.7B. The one-week bounce is notable but has not yet offset that broader trend. Health Care added $1.1B this week. Communication Services and Industrials took in smaller but positive amounts. Energy, Materials and Consumer Discretionary all saw outflows for the week. Industrials had been a solid three-month winner but softened to a near-neutral $325M inflow this week.
Asset Class and Strategy: Equities Lead, Active Managers Gaining
Equities absorbed $38.9B in net flows this week. Fixed Income added $8B. Both asset classes remain well bid over three months, with equities collecting $513.7B and fixed income $291.4B in that window. Commodities drew $650M this week and $33.4B over three months.
The strategy breakdown shows one clear divergence. Value ETFs bled $1.9B this week despite receiving $8.5B over three months. That is the sharpest short-term reversal in the strategy space. Growth ETFs took in $2.4B for the week, extending their three-month inflow of $18.7B. Active management continues to attract capital at pace. Active funds took in $7.4B this week, the second-largest strategy inflow behind passive Vanilla at $16.1B. Over three months, Active has pulled in $159.4B against Vanilla's $195.6B. Dividend strategies added $1.9B this week.
The MSCI November review adds a layer of index-driven flow to watch. MRNA sits 75% above its MSCI World re-entry line at a market cap of $88.5B. ORTEX's Index Rebalance Radar puts the probability of addition at 88%, with $5.9B of forced buying expected if confirmed. On the exit side, FLUT and TXT carry 70% and 69% deletion probabilities, with combined forced selling of $1.9B. The MSCI announcement falls on 11 November.
Overall, the week's tone is cautiously risk-on. Money is moving into equities and away from value and tech, with Asia replacing the domestic US tilt that dominated the past three months.
Stocks in this article
How this article was generated
- Generated
- 3 Nov 2026, 08:02
- Prompt version
- v1.0
- Data sources
- Institutional positioningORTEX Alpha signalsAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.